Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease

MT Armentero, A Pinna, S Ferré, JL Lanciego… - Pharmacology & …, 2011 - Elsevier
Several selective antagonists for adenosine A2A receptors (A2AR) are currently under
evaluation in clinical trials (phases I to III) to treat Parkinson's disease, and they will probably …
被引用次数：224 相关文章
[HTML] nih.gov

[HTML][HTML] Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease

MT Armentero, A Pinna, S Ferré… - Pharmacology & …, 2011 - ncbi.nlm.nih.gov
Several selective antagonists for adenosine A 2A receptors (A 2A R) are currently under
evaluation in clinical trials (phases I to III) to treat Parkinson's disease, and they will probably …

[引用][C] Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease

MT Armentero, A Pinna, S Ferré, JL Lanciego… - Pharmacology & …, 2011 - cir.nii.ac.jp
Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's
disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データを …

Past, present and future of A (2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

MT Armentero, A Pinna, S Ferré… - Pharmacology & …, 2011 - europepmc.org
Several selective antagonists for adenosine A 2A receptors (A 2A R) are currently under
evaluation in clinical trials (phases I to III) to treat Parkinson's disease, and they will probably …

Past, present and future of A (2A) adenosine receptor antagonists in the therapy of Parkinson's disease

MT Armentero, A Pinna, S Ferré… - … & Therapeutics, 2011 …, 2011 - diposit.ub.edu
Several selective antagonists for adenosine A2A receptors (A2AR) are currently under
evaluation in clinical trials (phases I to III) to treat Parkinson's disease, and they will probably …
[PDF] academia.edu

[PDF][PDF] Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease

MT Armentero, A Pinna, S Ferré, JL Lanciego… - Pharmacol …, 2011 - academia.edu
Several selective antagonists for adenosine A2A receptors (A2AR) are currently under
evaluation in clinical trials (phases I to III) to treat Parkinson's disease, and they will probably …

Past, present and future of A (2A) adenosine receptor antagonists in the therapy of Parkinson's disease

MT Armentero, A Pinna, S Ferré, JL Lanciego… - 2011 - recercat.cat
Several selective antagonists for adenosine A2A receptors (A2AR) are currently under
evaluation in clinical trials (phases I to III) to treat Parkinson's disease, and they will probably …

Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease

MT Armentero, A Pinna, S Ferré, JL Lanciego… - Pharmacology and …, 2011 - infona.pl
Several selective antagonists for adenosine A 2A receptors (A 2A R) are currently under
evaluation in clinical trials (phases I to III) to treat Parkinson's disease, and they will probably …

Past, present and future of A (2A) adenosine receptor antagonists in the therapy of Parkinson's disease

MT Armentero, A Pinna, S Ferré… - Pharmacology & …, 2011 - pubmed.ncbi.nlm.nih.gov
Several selective antagonists for adenosine A (2A) receptors (A (2A) R) are currently under
evaluation in clinical trials (phases I to III) to treat Parkinson's disease, and they will probably …
[PDF] academia.edu

[PDF][PDF] Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease

MT Armentero, A Pinna, S Ferré, JL Lanciego… - Pharmacol …, 2011 - academia.edu
Several selective antagonists for adenosine A2A receptors (A2AR) are currently under
evaluation in clinical trials (phases I to III) to treat Parkinson's disease, and they will probably …